Mai Zhang, MS

department of radiation oncology, XiJing hospital
Xian, Shanxi

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

2900 - Chemotherapy plus Nimotuzumab and Immunotherapy as Induction Regime Followed by Sequential Chemoradiotherapy and Consolidation Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm, Open-Label, Phase II Trial
Hall F
10:45am - 12:00pm PT